Patients with negative patch tests: Retrospective analysis of North American Contact Dermatitis Group (NACDG) data 2001-2016 - 16/05/19
, Donald V. Belsito, MD d, Joseph F. Fowler, MD e, James S. Taylor, MD f, Howard I. Maibach, MD g, Toby Mathias, MD h, Denis Sasseville, MD i, James G. Marks, MD j, Vincent A. DeLeo, MD k, Anthony F. Fransway, MD l, Kathryn A. Zug, MD m, Melanie D. Pratt, MD n, Matthew J. Zirwas, MD o, Joel G. DeKoven, MD pAbstract |
Background |
Little is known regarding the characteristics of patients with negative patch test (NPT) results.
Objective |
To characterize patients with NPT results.
Methods |
Retrospective cross-sectional analysis of 34,822 patch tested patients. NPT results were defined as negative or irritant final interpretations of all North American Contact Dermatitis Group screening allergens and no relevant allergens on supplemental series.
Results |
Almost one-third of patients (n = 10,888 [31.3%]) had NPT results. Patients with NPT results were significantly more likely to be male (P < .0001), be age 40 years or younger (P = .0054), be nonwhite (P = .0005), and have dermatitis primarily having a scattered generalized distribution (P = .0007) or primarily located on the lips (P = .0214) or eyelids (P = .0364). However, the absolute differences in age, race, and site were small and may not be clinically meaningful. Patients with NPT results were significantly less likely to have occupationally related skin disease (P < .0001). Overall, 8.3% of patients with NPT results had occupationally related skin disease, with precision production worker/machine operator (28.5%), health care worker (17.0%), and mechanic/repairer (7.5%) being the most commonly related occupations. In all, 22.9% of patients with NPT results had relevant irritants and 41.6% of irritants were occupationally related; cosmetics/health care products and soaps were common sources for both occupationally related and non–occupationally related irritants.
Limitations |
Retrospective cross-sectional study of tertiary referral population.
Conclusions |
Patients with NPT results have distinct characteristics.
Le texte complet de cet article est disponible en PDF.Key words : irritants, occupational, patch testing
Abbreviations used : CI, ESSCA, NACDG, NPT, PPT, RR, TRUE Test
Plan
| Funding sources: None. |
|
| Disclosure: Dr Taylor is a consultant for Johnson & Johnson, Bayer, Equinox Group, and Kao Brands and a stockholder for Johnson & Johnson, Express Scripts, Opko Health, and Astra Zeneca; in addition, he is an author for Decision Support in Medicine, and he has a nondependent child who is employed by Pfizer. Dr Zirwas is part owner of AsepticMD; a speaker, consultant, and investigator for Regeneron/Sanofi; a speaker for Genentech/Novartis; a consultant for Fit Bit, L'Oreal, and Menlo; and an investigator for Leo, Janssen, Incyte, Foamix, DS Biopharma, UCB, Pfizer, Lilly, Asana, and Avillion. Dr Warshaw, Mrs Zhang, Dr Mathias, Dr DeKoven, Dr Maibach, Dr Sasseville, Dr Belsito, Dr Fowler, Dr Zug, Dr Fransway, Dr DeLeo, Dr Marks, and Dr Pratt have no conflicts of interest to disclose. |
|
| This material is the result of work supported with resources and the use of facilities at the Minneapolis Veterans Affairs Medical Center. The contents do not represent the views of the US Department of Veterans Affairs or the United States Government. |
|
| Reprints not available from the authors. |
Vol 80 - N° 6
P. 1618-1629 - juin 2019 Retour au numéro
Article précédent
- Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients
- Chuandi Zhou, Fan Wu, Peiwei Chai, Yingyun Shi, Juan Ye, Xin Shi, Jia Tan, Yi Ding, Yingxiu Luo, Bita Esmaeli, Renbing Jia, Xianqun Fan
- Prevalence of clinically significant incidental findings by whole-body fludeoxyglucose F 18 positron emission tomography/computed tomography scanning in moderate-to-severe psoriasis patients participating in clinical trials
- Marilyn T. Wan, Drew A. Torigian, Abass Alavi, Judith Alvarez, Zelma C. Chiesa Fuxench, Megan H. Noe, Maryte Papadopoulos, Daniel B. Shin, Junko Takeshita, Thomas J. Werner, Nehal N. Mehta, Joel M. Gelfand
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?